Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the Literature
Abstract Background and Objective While successful treatment paradigms for BRAF V600 mutations have been developed, 10% of BRAF mutations are not at V600 and lack a standard treatment regimen.This study summarizes the current body of knowledge on the treatment of non-V600 mutations and reports a single institution experience.Methods We conducted a